Allion Healthcare, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Allion Healthcare, Inc. - overview
Established
1983
Location
Melville, NY, US
Primary Industry
Biotechnology
About
Allion Healthcare, Inc. is a healthcare solutions provider specializing in innovative health management and telehealth services aimed at enhancing patient engagement and improving healthcare delivery. Its offerings cater to diverse patient needs across various regions. Allion Healthcare, Inc.
offers comprehensive healthcare solutions designed to address patient needs. Established in 1983 and headquartered in Melville, US, the company has undergone strategic changes, including its transition from public to private ownership in a funding round led by H. I. G.
Capital, raising USD 278. 00 mn. The firm has completed two significant deals, with its most recent deal occurring on August 20, 2012, when AIDS Healthcare Foundation acquired MOMS Pharmacy, Inc. from Allion Healthcare.
The company was founded by Farah Meknini, who has a history of entrepreneurship in the healthcare sector, while the current CEO is Dante Rosati. Allion Healthcare specializes in providing innovative healthcare solutions that cater to a wide array of patient needs. The company's core offerings include a range of health management and telehealth services designed to enhance patient engagement and streamline healthcare delivery. Their solutions improve the quality of care by facilitating better communication between healthcare providers and patients, ultimately reducing barriers to access.
These services are utilized by healthcare providers, regional health organizations, and insurance companies across North America, Europe, and parts of Asia, addressing specific healthcare challenges such as chronic disease management and efficient coordination of care among stakeholders. Allion Healthcare generated revenue of USD 340. 67 mn in its most recent fiscal year, 2008. The company reported an EBITDA of USD 20.
96 mn for the same year. Allion's revenue model focuses on partnerships with healthcare providers and payers, implementing a subscription-based pricing plan for its telehealth and health management services. This framework supports scalable solutions for healthcare organizations, while collaborations with insurance companies enhance the integration of Allion’s services into healthcare plans. In light of its strategic growth, Allion Healthcare aims to expand its product offerings which include upcoming telehealth initiatives designed to further enhance patient engagement, with potential launches anticipated in the next fiscal year.
The company is also targeting expansion into additional markets in Europe and Asia by 2025. The recent funding from the Public to Private round will support these initiatives, allowing Allion to increase its capabilities in providing diverse healthcare solutions while strengthening its partnerships with healthcare providers and insurers.
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.allionhealthcare.com
Verticals
HealthTech
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Allion Healthcare, Inc. - financials
| Fiscal Year Ended | Dec 31, 2002 | Dec 31, 2003 | Dec 31, 2004 | Dec 31, 2005 | Dec 31, 2006 | Dec 31, 2007 | Dec 31, 2008 | Dec 31, 2009 | Jan 14, 2010 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 21,745,621 | - | 64,605,721 | 123,107,672 | 209,503,304 | 246,661,000 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | 90.6% | 70.2% | 17.7% | - | - | - |
| EBITDA (USD) | (561,167) | - | (1,660,434) | 3,481,891 | 6,500,171 | 7,947,000 | - | - | - |
| Operating Income (USD) | (683,992) | - | (2,377,415) | 1,512,486 | 2,943,317 | 4,373,000 | - | - | - |
| Operating Margin | (3.1%) | - | (3.7%) | 1.2% | 1.4% | 1.8% | - | - | - |
| % EBITDA Margin | (2.6%) | - | (2.6%) | 2.8% | 3.1% | 3.2% | - | - | - |
| NET Income (USD) | (655,992) | - | (2,680,148) | 404,970 | 3,190,240 | 3,260,000 | - | - | - |
| % Net Margin | (3.0%) | - | (4.1%) | 0.3% | 1.5% | 1.3% | - | - | - |
Allion Healthcare, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Allion Healthcare, Inc. | - | ||||||||
| Public to Private | Completed | Allion Healthcare, Inc. | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.